Business

Biogen partner sees FY25 launch for Leqembi home version (BIIB)

Posted by

[ad_1]

Alzheimers Concept Horizontal

travellinglight/iStock via Getty Images

  • Eisai (OTCPK:ESALF), Biogen’s (NASDAQ:BIIB) partner for Alzheimer’s therapy Leqembi is planning to launch its at-home version of the drug in fiscal 2025, Japanese business publication Nikkei Asia reported Thursday.
  • “The new formulation will be a game changer in Alzheimer’s treatment,” Eisai (

[ad_2]

Leave a Reply

Your email address will not be published. Required fields are marked *